Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia

Frontiers in Medicine

Eline van Overbeeke¹  Isabelle Huys¹  Steven Simoens¹  Sissel Michelsen²  Brett Hauber³  Michel Goldman⁴ 

[1] Clinical Pharmacology and Pharmacotherapy, University of Leuven, Leuven, Belgium;Clinical Pharmacology and Pharmacotherapy, University of Leuven, Leuven, Belgium;Healthcare Management Centre, Vlerick Business School, Ghent, Belgium;Health Preference Assessment, RTI Health Solutions, Durham, NC, United States;Institute for Interdisciplinary Innovation in Healthcare, Université Libre de Bruxelles, Brussels, Belgium;

关键词: preference;    instrument design;    hemophilia;    interviews;    survey;    gene therapy;   

DOI  :  10.3389/fmed.2021.595797

来源: Frontiers

【 授权许可】

CC BY